Sulfadoxine

Comprehensive Product Overview

In the landscape of antimicrobial therapy, Sulfadoxine is distinguished by its sustained duration of action. Like other sulfa drugs, it inhibits bacterial and protozoal growth by interfering with the synthesis of dihydrofolic acid. Specifically, it competes with para-aminobenzoic acid (PABA) for the enzyme dihydropteroate synthase. Because of its slow excretion rate, it remains active in the body for an extended period, making it ideal for prophylactic treatments and intermittent preventive therapies. Zyntex provides Sulfadoxine with high chemical stability, ensuring it remains effective even in challenging environmental conditions.

Zyntex also specializes in supplying Sulfadoxine for synergistic drug combinations. When paired with pyrimethamine, it creates a powerful sequential blockade of the folic acid pathway, which is highly effective against Plasmodium falciparum malaria. In addition to its anti-malarial use, it is a vital component in veterinary medicine for treating respiratory, urinary, and gastrointestinal infections in cattle, swine, and poultry. Our API is produced under strict quality control measures to meet international pharmacopeia standards, guaranteeing high bioavailability and minimal impurity levels. Consequently, our product supports manufacturers in developing life-saving medications with reliable dosing intervals. Finally, our logistical expertise ensures that your supply chain remains robust and efficient.

Key Pharmaceutical & Veterinary Applications

This long-acting antimicrobial API is essential for the following specialized sectors:

Technical Specifications